Duodenoscopes Market Size, Share & Industry Analysis, By Product Type (Reusable and Disposable), By Application (Diagnostic {Biliary Disorders, Pancreatic Disorders, and Others} and Therapeutic {Stone Removal, Stent Placement, Sphincterotomy, and Others}), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global duodenoscopes market size was valued at USD 1.08 billion in 2025. The market is projected to grow from USD 1.16 billion in 2026 to USD 2.22 billion by 2034, exhibiting a CAGR of 8.4% during the forecast period.

Duodenoscopes are specialized flexible endoscopes used mainly in Endoscopic Retrograde Cholangiopancreatography (ERCP) to access the duodenum, pancreatic duct, bile duct, and papilla for diagnosis and treatment. The market is growing due to rising gastrointestinal, biliary, and pancreatic disorders, which are supporting the adoption of duodenoscopes.

Olympus Corporation, Boston Scientific Corporation, and Ambu A/S held the highest market share in 2025. This was attributed to the strong brand reputation of these companies, their focus on innovations, and strategic initiatives for geographic expansion.

DUODENOSCOPES MARKET TRENDS

Hybrid Safety Designs are Becoming the New Competitive Standard

Currently, there has been a significant shift away from conventional fixed-endcap devices toward hybrid safety models such as the reusable scopes with disposable distal caps, fully single-use duodenoscopes, and reusable scopes validated for advanced sterilization. FDA recommendations, hospital infection-prevention committees, and manufacturer innovation are shaping this trend. Instead of competing only on optics and handling, vendors are now differentiating on sterility assurance, distal-end access, disposable components, cleaning workflow, sustainability, and compatibility with reprocessing systems.

• For instance, in September 2025, FUJIFILM Holdings Corporation launched its new ED-840T video duodenoscope for Hepato-Pancreato-Biliary (HPB) care in Europe, featuring a large 4.5 mm instrument channel and improved tip design for better insertion.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising ERCP Demand and Stronger Infection-Control Needs to Fuel Market Expansion

Over the past few years, there has been a significant surge in the use of ERCP for therapeutic pancreaticobiliary procedures, especially in hospitals managing gallstones, strictures, tumors, pancreatitis-related complications, and biliary obstruction. ERCP has shifted from a diagnostic procedure to a largely therapeutic intervention, creating demand for scopes with better visualization, elevator control, accessory compatibility, and procedural efficiency. At the same time, infection-control scrutiny is pushing providers toward disposable components, validated sterilization, and fully single-use designs. All these factors are anticipated to boost the duodenoscopes market growth in the coming years.

MARKET RESTRAINTS

High Cost and Complex Reprocessing to Restrict Market Growth

Reusable duodenoscopes require high upfront capital investment, dedicated reprocessing infrastructure, trained staff, maintenance, repair, drying/storage systems, and compliance documentation. Furthermore, single-use duodenoscopes reduce reprocessing-related contamination concerns. Still, their per-procedure cost can be difficult for high-volume centers, price-sensitive hospitals, and ambulatory settings unless reimbursement or risk-based procurement policies support adoption. Moreover, infection-control concerns increase hidden costs such as surveillance cultures, staff time, scope downtime, and liability risk. This creates purchasing pressure. Such a scenario is anticipated to limit the adoption of duodenoscopes, thereby hindering market expansion.

MARKET OPPORTUNITIES

Growing Utilization of Sterile, Single-Use, and Sterilizable Reusable Platforms to Offer Lucrative Opportunities

In recent years, there has been a growing use of platforms that reduce contamination risk without disrupting ERCP workflow. Fully single-use duodenoscopes are supporting urgent, immunocompromised, or high-risk cases where reprocessing confidence is critical. At the same time, sterilizable reusable designs help hospitals retain familiar performance and improve infection-control assurance. This is leading to an increase in approvals and clearances for sterile-use systems, creating a significant opportunity for market growth.

• For instance, in August 2024, Ambu A/S received FDA clearance for its new-generation single-use duodenoscopy solution, the Ambu aScope Duodeno 2, designed to improve ERCP procedure performance.

MARKET CHALLENGES

Stringent Regulations to Challenge Market Expansion

Duodenoscopes are complex, with the elevator mechanism and distal tip being difficult to clean, inspect, and validate, making reprocessing compliance resource-intensive. In addition, the regulatory and recall activity continues to affect buyer confidence. For instance, in January 2023, the FDA's Center for Devices and Radiological Health (CDRH) issued 2023 warning letters to Olympus Medical Systems and Aizu Olympus related to medical device reporting and quality-system requirements for endoscopes, including duodenoscopes.

• Similarly, in October 2025, Olympus Corporation recalled its EVIS EXERA III duodenovideoscope due to continued reports of positive cultures and infections.

Single-use devices raise questions around waste, procurement budgets, storage, and case-by-case utilization policies. Therefore, market adoption depends on product innovation and on staff training, reimbursement, and hospital risk tolerance, challenging market growth.

Segmentation Analysis

By Product Type

Large Installed Bases of Reusable Duodenoscopes Fueled Segment Growth

Based on product type, the market is segmented into reusable and disposable.

The reusable segment accounted for the largest global duodenoscopes market share in 2025. Reusable duodenoscopes already have large installed bases, trained endoscopy teams, reprocessing departments, repair workflows, and budgets built around repeated use. As a result, they remain attractive in high-volume ERCP centers, which is anticipated to fuel the segment’s growth in the coming years.

The disposable segment is projected to grow at a 12.2% CAGR during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Therapeutic Segment Led Market Due to Growing Usage of ERCP to Treat Pancreaticobiliary Disease

By application, the market is segmented into diagnostic and therapeutic.

The therapeutic segment accounted for the largest market share in 2025. The segment’s growth is attributed to increasing use of ERCP to treat pancreaticobiliary disease rather than only diagnose it. Duodenoscopes enable stone extraction, sphincterotomy, biliary and pancreatic drainage, stent placement, stricture dilation, and other accessory-based interventions through the working channel and elevator mechanism, which is driving their usage.

The diagnostic segment is anticipated to grow at a 6.9% CAGR over the forecast period.

By End-user

Increasing Diagnostic and Interventional Endoscopic Procedures in Hospitals & ASCs Propelled Segment Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others.

In 2025, hospitals & ASCs dominated the market. ERCP requires skilled gastroenterologists, fluoroscopy access, anesthesia support, accessory inventory, and emergency backup. As a result, these procedures are highly performed in hospitals. Moreover, ASCs are gaining importance as minimally invasive procedures are shifting outside inpatient settings. Also, an increasing number of ASCs is further expected to fuel the segment’s growth. Furthermore, the segment is set to hold an 84.6% share in 2026.

• For instance, according to the data from the Ambulatory Surgery Center Association, there are over 6,500 Medicare-certified ASCs in the U.S.

The specialty clinics segment is projected to grow at a CAGR of 10.6% during the forecast period.

Duodenoscopes Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest market share in 2024 with USD 0.37 billion and was valued at USD 0.40 billion in 2025. The region’s growth is attributed to the high ERCP procedure volumes, advanced hospital endoscopy infrastructure, strong adoption of premium systems, and strict infection-prevention regulations.

• For instance, in June 2022, the U.S. FDA stated that the duodenoscopes are utilized in more than 500,000 ERCP procedures annually in the country.

U.S. Duodenoscopes Market

In 2026, the U.S. is anticipated to reach USD 0.40 billion, accounting for approximately 34.3% of the global revenues.

Europe

Europe is projected to record a 7.2% growth rate during the forecast period and is expected to be the second-highest globally, reaching USD 0.34 billion in 2026. Established gastroenterology centers, high awareness of endoscope reprocessing standards, and adoption of advanced systems across Germany, France, the U.K., Italy, Spain, and Nordic countries are expected to support the regional market growth.

U.K. Duodenoscopes Market

The U.K. market is projected to reach USD 0.05 billion in 2026, representing approximately 4.5% of global revenues.

Germany Duodenoscopes Market

Germany's market is expected to reach USD 0.07 billion in 2026, accounting for approximately 6.4% of global revenues.

Asia Pacific

In 2026, Asia Pacific is projected to reach approximately USD 0.32 billion, making it the third-largest market globally. The region’s growth is due to a large patient base of pancreatic cancer, improving healthcare infrastructure, rising gastrointestinal and biliary disease burden, and increasing access to advanced endoscopy procedures.

Japan Duodenoscopes Market

Japan is projected to generate approximately USD 0.11 billion in 2026, representing nearly 9.4% of global revenues.

China Duodenoscopes Market

China’s market is anticipated to reach around USD 0.12 billion in 2026, accounting for nearly 10.5% of global revenues.

India Duodenoscopes Market

India’s market is expected to reach approximately USD 0.03 billion in 2026, accounting for around 2.3% of global revenues.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa are anticipated to witness moderate growth, with the Latin America market estimated to reach approximately USD 0.04 billion in 2026. The growth is supported by investment in specialty hospitals, increasing prevalence of gastrointestinal diseases, and growing awareness of duodenoscopy in these regions.

GCC Duodenoscopes Market

In 2026, the GCC market is estimated to reach approximately USD 0.01 billion, representing around 1.0% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Leading Companies Emphasize Broad Product Offerings and Robust Distribution Networks to Enhance Their Market Positions

In 2025, Olympus Corporation, Boston Scientific Corporation, and Ambu A/S held the largest global market share. This share is attributed to a large installed base globally and a strong brand reputation, with an established footprint in developed countries globally. Moreover, other key players are focusing on offering cost-effective products, launching innovative products, and increasing their focus on geographic expansion through partnerships, collaborations, and acquisitions.

LIST OF KEY DUODENOSCOPE COMPANIES PROFILED:

• Olympus Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• PENTAX Medical (Japan)
• Ambu A/S (Denmark)
• SonoScape Medical Corp (China)
• Ottomed (India)
• MITRA Industries (India)
• KARL STORZ SE & Co. KG (Germany)

KEY INDUSTRY DEVELOPMENTS

• January 2026: ASP announced CE marking for the ULTRA GI Cycle for duodenoscopes in partnership with FUJIFILM Healthcare Europe, adding ED-840T and ED-840XT compatibility.
• September 2025: FUJIFILM Holdings Corporation announced the European launch of the ED-840T video duodenoscope for hepato-pancreato-biliary care.
• September 2025: FUJIFILM Holdings Corporation launched the ED-840T duodenoscope in Japan, featuring a large 4.5 mm instrument channel, redesigned tip, and support for biliary and pancreatic endoscopic therapy.
• September 2025: PENTAX Medical and ASP launched the Sterilizable DEC Duodenoscope in the U.S., designed for complete sterilization in 68 minutes using the STERRAD system.
• August 2024: PENTAX Medical received FDA clearance for its DEC Duodenoscope compatibility with ASP’s STERRAD 100NX Sterilizer.
• August 2024: Ambu A/S received CE marking for aScope Duodeno 2 and aBox 2 and continued its controlled market release in the U.S. and Europe.
• April 2024: Ambu A/S obtained FDA 510(k) clearance for aScope Duodeno 2 and aBox 2 for ERCP procedures.

REPORT COVERAGE

The report provides a comprehensive assessment of the duodenoscopes market, covering all major market segments and sub-segments to understand their growth potential, adoption trends, and revenue contribution. It highlights the key factors driving market expansion. The study also evaluates emerging trends, growth opportunities, restraints, and operational challenges influencing market dynamics across major regions. In addition, the report offers detailed insights into technological advancements, new product launches, procedure volumes, competitive analysis, and company profiles of major market players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation